Colorectal Cancer Screening Market Size, Share, Trends, Growth Outlook

Colorectal Cancer Screening Market is estimated to increase at a Compounded Annual Growth Rate of 6.8% CAGR over the forecast period from 2024 to 2030

The Colorectal Cancer Screening Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments- By Screening Test (Stool-based Tests, Colonoscopy, CT Colonography, Flexible Sigmoidoscopy, Others), By End-User (Hospitals, Independent Diagnostic Labs, Others).

An Introduction to Colorectal Cancer Screening Market in 2024

In 2024, the market for colorectal cancer screening aims to address the global burden of colorectal cancer by offering effective screening modalities, population-based screening programs, and risk assessment tools for early detection and prevention of colorectal neoplasia. Colorectal cancer screening plays a crucial role in reducing disease incidence, morbidity, and mortality by detecting precancerous polyps and early-stage malignancies when treatment is most effective. Screening methods include fecal occult blood tests (FOBT), fecal immunochemical tests (FIT), colonoscopy, sigmoidoscopy, and virtual colonoscopy (CT colonography), each with its advantages and limitations in terms of sensitivity, specificity, and patient acceptability. With a focus on screening program implementation, outreach initiatives, and patient engagement strategies, the colorectal cancer screening market aims to increase screening uptake, reduce disparities in access to care, and promote public awareness of the importance of early detection in preventing colorectal cancer-related deaths.

Market Trend: Adoption of Non-Invasive Screening Technologies

A significant trend in the Colorectal Cancer Screening market is the increasing adoption of non-invasive screening technologies. As awareness about the importance of early detection and prevention of colorectal cancer grows, there's a shift towards non-invasive screening methods that offer convenience, comfort, and high compliance rates among individuals eligible for screening. Non-invasive screening tests such as fecal immunochemical tests (FIT), stool DNA tests, and blood-based biomarker assays provide viable alternatives to traditional invasive methods like colonoscopy. These non-invasive tests offer advantages such as ease of use, minimal discomfort, and no requirement for bowel preparation, making them more accessible and appealing to individuals who may be hesitant to undergo colonoscopy. The adoption of non-invasive screening technologies represents a prominent trend in the Colorectal Cancer Screening market, driving innovation in diagnostic approaches and expanding screening participation rates among at-risk populations.

Market Driver: Increasing Incidence of Colorectal Cancer and Aging Population

An important driver fueling the Colorectal Cancer Screening market is the increasing incidence of colorectal cancer globally, coupled with the aging population. Colorectal cancer is one of the most common malignancies worldwide, with millions of new cases diagnosed each year. Factors such as aging populations, sedentary lifestyles, unhealthy dietary habits, and rising prevalence of risk factors such as obesity and smoking contribute to the growing incidence of colorectal cancer. Additionally, the majority of colorectal cancer cases occur in individuals aged 50 and older, highlighting the importance of targeted screening efforts in this demographic group. The need for early detection and timely intervention to improve patient outcomes drives demand for colorectal cancer screening tests and programs, creating opportunities for healthcare providers, diagnostic manufacturers, and policymakers to implement effective screening strategies and increase screening uptake rates among eligible populations.

Market Opportunity: Expansion of Population-Based Screening Programs

A significant opportunity within the Colorectal Cancer Screening market lies in the expansion of population-based screening programs and initiatives. Despite the proven effectiveness of colorectal cancer screening in reducing mortality rates and improving patient outcomes, screening uptake rates remain suboptimal in many regions worldwide. Expanding population-based screening programs and increasing awareness about the importance of colorectal cancer screening among healthcare providers and the general public can help address disparities in screening participation and improve early detection rates. Opportunities exist for governments, healthcare organizations, and advocacy groups to implement targeted outreach and education campaigns, reduce barriers to screening access, and promote the adoption of evidence-based screening guidelines. By investing in population-based screening initiatives and fostering collaboration between stakeholders, the Colorectal Cancer Screening market can capitalize on the opportunity to enhance screening uptake rates, reduce colorectal cancer incidence and mortality, and improve public health outcomes on a global scale.

Colorectal Cancer Screening Market Share Analysis: Stool-based Tests

Among the various screening tests used in the colorectal cancer screening market, stool-based tests are experiencing the fastest growth. Stool-based tests include fecal occult blood tests (FOBT), fecal immunochemical tests (FIT), and stool DNA tests (sDNA), which are non-invasive methods for detecting blood or genetic alterations associated with colorectal cancer in stool samples. The rapid growth of stool-based tests in the colorectal cancer screening market can be attributed to several factors. Firstly, stool-based tests offer several advantages over invasive screening methods such as colonoscopy, including convenience, ease of use, and non-invasiveness, which contribute to higher patient acceptance and compliance rates. Stool-based tests can be performed at home without the need for dietary restrictions or bowel preparation, making them more accessible and convenient for individuals hesitant to undergo invasive procedures. Secondly, advancements in stool-based test technology, such as the development of highly sensitive and specific immunochemical and molecular assays, have improved the accuracy and reliability of colorectal cancer detection, leading to increased adoption in population-based screening programs and clinical practice. Additionally, the endorsement of stool-based tests by professional organizations and healthcare authorities as viable options for colorectal cancer screening, either as stand-alone tests or in combination with other screening modalities, further drives market growth. Furthermore, the growing emphasis on early detection and prevention of colorectal cancer, coupled with population aging and increasing disease burden, fuels the demand for non-invasive and cost-effective screening strategies, positioning stool-based tests as key components of colorectal cancer screening programs worldwide.

Colorectal Cancer Screening Competitive Analysis

The market research study provides in-depth insights into leading companies including the SWOT analyses, product profile, financial details, and recent developments acrossEiken Chemical Co. Ltd, Epigenomics Inc, Exact Sciences Corp, F. Hoffmann-La Roche AG, Hemosure Inc, Olympus Corp, Polymedco Inc, QuidelOrtho Corp, Siemens Healthineers AG, Sysmex Corp

Colorectal Cancer Screening Market Segmentation

By Screening Test
Stool-based Tests
Colonoscopy
CT Colonography (Virtual Colonoscopy)
Flexible Sigmoidoscopy
Others
By End-User
Hospitals
Independent Diagnostic Labs
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Colorectal Cancer Screening Market Companies

Eiken Chemical Co. Ltd
Epigenomics Inc
Exact Sciences Corp
F. Hoffmann-La Roche AG
Hemosure Inc
Olympus Corp
Polymedco Inc
QuidelOrtho Corp
Siemens Healthineers AG
Sysmex Corp

Reasons to Buy the Colorectal Cancer Screening Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Colorectal Cancer Screening Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Colorectal Cancer Screening Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Colorectal Cancer Screening Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Covered
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Colorectal Cancer Screening Market Size Outlook, $ Million, 2021 to 2030
3.2 Colorectal Cancer Screening Market Outlook by Type, $ Million, 2021 to 2030
3.3 Colorectal Cancer Screening Market Outlook by Product, $ Million, 2021 to 2030
3.4 Colorectal Cancer Screening Market Outlook by Application, $ Million, 2021 to 2030
3.5 Colorectal Cancer Screening Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Colorectal Cancer Screening Industry
4.2 Key Market Trends in Colorectal Cancer Screening Industry
4.3 Potential Opportunities in Colorectal Cancer Screening Industry
4.4 Key Challenges in Colorectal Cancer Screening Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Colorectal Cancer Screening Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Colorectal Cancer Screening Market Outlook by Segments
7.1 Colorectal Cancer Screening Market Outlook by Segments, $ Million, 2021- 2030
By Screening Test
Stool-based Tests
Colonoscopy
CT Colonography (Virtual Colonoscopy)
Flexible Sigmoidoscopy
Others
By End-User
Hospitals
Independent Diagnostic Labs
Others

8 North America Colorectal Cancer Screening Market Analysis and Outlook To 2030
8.1 Introduction to North America Colorectal Cancer Screening Markets in 2024
8.2 North America Colorectal Cancer Screening Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Colorectal Cancer Screening Market size Outlook by Segments, 2021-2030
By Screening Test
Stool-based Tests
Colonoscopy
CT Colonography (Virtual Colonoscopy)
Flexible Sigmoidoscopy
Others
By End-User
Hospitals
Independent Diagnostic Labs
Others

9 Europe Colorectal Cancer Screening Market Analysis and Outlook To 2030
9.1 Introduction to Europe Colorectal Cancer Screening Markets in 2024
9.2 Europe Colorectal Cancer Screening Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Colorectal Cancer Screening Market Size Outlook by Segments, 2021-2030
By Screening Test
Stool-based Tests
Colonoscopy
CT Colonography (Virtual Colonoscopy)
Flexible Sigmoidoscopy
Others
By End-User
Hospitals
Independent Diagnostic Labs
Others

10 Asia Pacific Colorectal Cancer Screening Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Colorectal Cancer Screening Markets in 2024
10.2 Asia Pacific Colorectal Cancer Screening Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Colorectal Cancer Screening Market size Outlook by Segments, 2021-2030
By Screening Test
Stool-based Tests
Colonoscopy
CT Colonography (Virtual Colonoscopy)
Flexible Sigmoidoscopy
Others
By End-User
Hospitals
Independent Diagnostic Labs
Others

11 South America Colorectal Cancer Screening Market Analysis and Outlook To 2030
11.1 Introduction to South America Colorectal Cancer Screening Markets in 2024
11.2 South America Colorectal Cancer Screening Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Colorectal Cancer Screening Market size Outlook by Segments, 2021-2030
By Screening Test
Stool-based Tests
Colonoscopy
CT Colonography (Virtual Colonoscopy)
Flexible Sigmoidoscopy
Others
By End-User
Hospitals
Independent Diagnostic Labs
Others
12 Middle East and Africa Colorectal Cancer Screening Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Colorectal Cancer Screening Markets in 2024
12.2 Middle East and Africa Colorectal Cancer Screening Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Colorectal Cancer Screening Market size Outlook by Segments, 2021-2030
By Screening Test
Stool-based Tests
Colonoscopy
CT Colonography (Virtual Colonoscopy)
Flexible Sigmoidoscopy
Others
By End-User
Hospitals
Independent Diagnostic Labs
Others

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Eiken Chemical Co. Ltd
Epigenomics Inc
Exact Sciences Corp
F. Hoffmann-La Roche AG
Hemosure Inc
Olympus Corp
Polymedco Inc
QuidelOrtho Corp
Siemens Healthineers AG
Sysmex Corp

14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Screening Test
Stool-based Tests
Colonoscopy
CT Colonography (Virtual Colonoscopy)
Flexible Sigmoidoscopy
Others
By End-User
Hospitals
Independent Diagnostic Labs
Others
Countries Analyzed
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)